Government Briefs

‘When biologist David Baltimore testified earlier this month before a congressional panel that has spent two years investigating charges of impropriety in connection with his 1986 paper in Cell, he wasn’t alone. Sitting in. the audience and offering moral support to the director of MIT’s Whitehead Institute were some two dozen colleagues, many with scientific reputations to match the Nobel laureate’s. “David is very important to the scientific community,” say

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

‘When biologist David Baltimore testified earlier this month before a congressional panel that has spent two years investigating charges of impropriety in connection with his 1986 paper in Cell, he wasn’t alone. Sitting in. the audience and offering moral support to the director of MIT’s Whitehead Institute were some two dozen colleagues, many with scientific reputations to match the Nobel laureate’s. “David is very important to the scientific community,” says Columbia University’s Eric Kandel. Asked to explain why he hopped on a plane to spend nine hours in a hearing room listening to members of Congress attack a piece of research that he was not involved with, the neuroscientist answered, “What happens to him affects all of us.” Although members of the House Energy and Commerce oversight subcommittee insist that they are not trying to judge the merits of the work itself, Baltimore told the panel that “there are many ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies